Sign in
XCUR Stock Price, Chart, Stats & News
Exicure, Inc.
Save
14.72M
Market cap
–
Current P/E
–
Forward P/E
XCUR chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | 11.36% |
ROA | -35.23% |
ROE | -63.62% |
D/E | 0.04x |
Interest coverage ratio | -4207.00x |
XCUR valuation
P/E | – |
P/S | – |
P/B | 7.08x |
P/CF | -3.25x |
P/FCF | -1.93x |
P/OCF | -3.25x |
PEG | -0.11x |
EV multiple | -3.28x |
About
Exicure, Inc. is a biotechnology firm that utilizes its unique spherical nucleic acid (SNA) platform to create therapies for neurological conditions and hair loss. Its primary experimental candidate, SCN9A, is currently undergoing preclinical evaluation for addressing neuropathic and chronic pain. The company has entered into a strategic partnership with AbbVie Inc. to advance SNA-based solutions for various hair loss conditions, under a collaboration, option, and license agreement.
Similar securities
Based on sector and market capitalization
Report issue